Insider Selling: Genesis Healthcare Inc (GEN) CFO Sells 5,899 Shares of Stock

Genesis Healthcare Inc (NYSE:GEN) CFO Thomas Divittorio sold 5,899 shares of Genesis Healthcare stock in a transaction that occurred on Tuesday, June 12th. The stock was sold at an average price of $2.28, for a total value of $13,449.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Thomas Divittorio also recently made the following trade(s):

  • On Tuesday, June 5th, Thomas Divittorio sold 9,404 shares of Genesis Healthcare stock. The stock was sold at an average price of $2.19, for a total value of $20,594.76.

Shares of GEN traded up $0.25 on Thursday, reaching $2.65. 1,813,857 shares of the stock traded hands, compared to its average volume of 714,116. The stock has a market cap of $366.72 million, a PE ratio of -1.27 and a beta of 1.00. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of -2.80. Genesis Healthcare Inc has a 12 month low of $0.60 and a 12 month high of $2.70.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings data on Thursday, May 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.34). The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.32 billion. During the same quarter in the previous year, the company posted ($0.55) EPS. equities analysts forecast that Genesis Healthcare Inc will post -1.32 earnings per share for the current fiscal year.

Several brokerages have commented on GEN. Stifel Nicolaus set a $2.00 price target on Genesis Healthcare and gave the stock a “hold” rating in a research report on Tuesday, April 24th. ValuEngine downgraded Genesis Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Stephens reaffirmed a “hold” rating and issued a $2.00 price target on shares of Genesis Healthcare in a research report on Monday, March 19th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Genesis Healthcare currently has a consensus rating of “Hold” and an average target price of $2.00.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. V3 Capital Management L.P. increased its position in shares of Genesis Healthcare by 2.0% during the fourth quarter. V3 Capital Management L.P. now owns 2,261,899 shares of the company’s stock valued at $1,726,000 after purchasing an additional 44,500 shares during the period. BSW Wealth Partners increased its position in shares of Genesis Healthcare by 74.2% during the first quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock valued at $174,000 after purchasing an additional 49,000 shares during the period. California Public Employees Retirement System increased its position in shares of Genesis Healthcare by 23.3% during the first quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock valued at $468,000 after purchasing an additional 58,610 shares during the period. Millennium Management LLC increased its position in shares of Genesis Healthcare by 40.6% during the first quarter. Millennium Management LLC now owns 338,678 shares of the company’s stock valued at $511,000 after purchasing an additional 97,834 shares during the period. Finally, Schwab Charles Investment Management Inc. bought a new stake in shares of Genesis Healthcare during the first quarter valued at approximately $153,000. Institutional investors and hedge funds own 18.70% of the company’s stock.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply